Pure Global AI
ANVISA registration 80000230104Valid until Nov 03, 2035

PROBES FOR LEUKEMIA AND LYMPHOMA MARKERS

ANVISA Registration Number: 80000230104AGILENT TECHNOLOGIES BRASIL LTDAAGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.Risk Class III
Device names
Technical name
PROBES FOR LEUKEMIA AND LYMPHOMA MARKERS
PT: SONDAS PARA MARCADORES DE LEUCEMIAS E LINFOMAS
Commercial name
Família de Marcadores de Carcinomas de Linfomas e Leucemias (Dako Omnis)
Risk class
Class III
Registration details
Registration Number
80000230104
Process Number
25351139182202515
CNPJ
03290250000100
Company information
Manufacturing Country
Singapore
PT: SINGAPURA, REPÚBLICA DA
Dates and status
Publication Date
Nov 03, 2025
Validity
03/11/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for PROBES FOR LEUKEMIA AND LYMPHOMA MARKERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80000230104 and manufactured by AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until Nov 03, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.